Yanru Li

The Key Laboratory Of Pathobiology
Changchun, 130021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Tumor's Own Blood Supply: Decoding Vasculogenic Mimicry through Hypoxia, EMT, and Epigenetics.

Tumor's Own Blood Supply: Decoding Vasculogenic Mimicry through Hypoxia, EMT, and Epigenetics.

Journal: Critical reviews in oncology/hematology

Published: March 28, 2026

Mitochondrial Quality Control and Cell Death.

Mitochondrial Quality Control and Cell Death.

Journal: International journal of molecular sciences

Published: October 15, 2025

Angiotensin II-Induced Ferroptosis in Epithelial Cells Contributes to Kidney Injury via SP1-DPEP1-Mediated SLC3A2 Degradation.

Angiotensin II-Induced Ferroptosis in Epithelial Cells Contributes to Kidney Injury via SP1-DPEP1-Mediated SLC3A2 Degradation.

Journal: Diabetes

Published: July 14, 2025

Is pyroptosis a brake or an accelerator in the fate of the tumor?

Is pyroptosis a brake or an accelerator in the fate of the tumor?

Journal: Cell death & disease

Published: July 20, 2024

Claudins and hepatocellular carcinoma.

Claudins and hepatocellular carcinoma.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 04, 2023

Independent prognostic value of CLDN6 in bladder cancer based on M2 macrophages related signature.

Independent prognostic value of CLDN6 in bladder cancer based on M2 macrophages related signature.

Journal: iScience

Published: August 09, 2023

Molecular mechanisms of Thrombospondin-2 modulates tumor vasculogenic mimicry by PI3K/AKT/mTOR signaling pathway.

Molecular mechanisms of Thrombospondin-2 modulates tumor vasculogenic mimicry by PI3K/AKT/mTOR signaling pathway.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 28, 2023

The Expression of CLDN6 in Hepatocellular Carcinoma Tissue and the Effects of CLDN6 on Biological Phenotypes of Hepatocellular Carcinoma Cells.

The Expression of CLDN6 in Hepatocellular Carcinoma Tissue and the Effects of CLDN6 on Biological Phenotypes of Hepatocellular Carcinoma Cells.

Journal: Journal of Cancer

Published: November 10, 2020

Estrogen receptor β inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy.

Estrogen receptor β inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 18, 2019

ERα is required for suppressing OCT4-induced proliferation of breast cancer cells via DNMT1/ISL1/ERK axis.

ERα is required for suppressing OCT4-induced proliferation of breast cancer cells via DNMT1/ISL1/ERK axis.

Journal: Cell proliferation

Published: December 18, 2018

Identification of genes and pathways associated with MDR in MCF-7/MDR breast cancer cells by RNA-seq analysis.

Identification of genes and pathways associated with MDR in MCF-7/MDR breast cancer cells by RNA-seq analysis.

Journal: Molecular medicine reports

Published: September 28, 2017

CLDN6 promotes chemoresistance through GSTP1 in human breast cancer.

CLDN6 promotes chemoresistance through GSTP1 in human breast cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 02, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026